Assessing vascular risk in people with type 1 diabetes: Implications for the effectiveness of statin therapy

被引：2
|
作者：
McKnight, J. A. [1 ]
机构：
[1] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
DIABETIC MEDICINE | 2007年 / 24卷 / 06期
关键词：
D O I：
10.1111/j.1464-5491.2007.02134.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：575 / 578
页数：4
相关论文
共 50 条
  • [41] Assessing the Actual Clinical Effectiveness of Metabolic/Bariatric Surgery for the Type 2 Diabetes Therapy
    Gian Franco Adami
    Renzo Cordera
    Obesity Surgery, 2017, 27 : 1886 - 1888
  • [42] RISK OF CARDIOVASCULAR DISEASES IN PEOPLE WITH TYPE 1 DIABETES MELLITUS
    Chalakova, Tatyana
    Yotov, Yoto
    Tsochev, Kaloyan
    Bocheva, Yana
    Iotova, Violeta
    Usheva, Natalya
    Galcheva, Sonya
    Valchev, Georgi
    JOURNAL OF HYPERTENSION, 2021, 39 : E177 - E178
  • [43] Cardiovascular Disease Risk in Young People with Type 1 Diabetes
    Snell-Bergeon, Janet K.
    Nadeau, Kristen
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2012, 5 (04) : 446 - 462
  • [44] Cardiovascular Disease Risk in Young People with Type 1 Diabetes
    Janet K. Snell-Bergeon
    Kristen Nadeau
    Journal of Cardiovascular Translational Research, 2012, 5 : 446 - 462
  • [45] Statin therapy and risk of polyneuropathy in type 2 diabetes: a population-based cohort study
    Christensen, D. H.
    Kristensen, F. P.
    Callaghan, B. C.
    Knudsen, S. T.
    Sindrup, S. H.
    Feldman, E. L.
    Ostergaard, L.
    Andersen, H.
    Jensen, T. S.
    Sorensen, H. T.
    Thomsen, R. W.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S93 - S94
  • [46] Statin therapy and risk of polyneuropathy in type 2 diabetes: A population-based cohort study
    Kristensen, Frederik Pagh
    Christensen, Diana Hedevang
    Callaghan, Brian
    Knudsen, Soren Tang
    Sindrup, Soren H.
    Feldman, Eva L.
    Ostergaard, Leif
    Andersen, Henning
    Jensen, Troels Staehelin
    Sorensen, Henrik Toft
    Thomsen, Reimar Wernich
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 62 - 62
  • [47] Clinical Implications of Lipohypertrophy Among People with Type 1 Diabetes in India
    Gupta, Sunil S.
    Gupta, Kavita S.
    Gathe, Sachin S.
    Bamrah, Parvinder
    Gupta, Shlok S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (07) : 483 - 491
  • [48] Assessing the cost-effectiveness of Type1 diabetes interventions: the Sheffield Type1 Diabetes Policy Model
    Thokala, P.
    Kruger, J.
    Brennan, A.
    Basarir, H.
    Duenas, A.
    Pandor, A.
    Gillett, M.
    Elliott, J.
    Heller, S.
    DIABETIC MEDICINE, 2014, 31 (04) : 477 - 486
  • [49] The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter?
    Benes, Lane B.
    Bassi, Nikhil S.
    Davidson, Michael H.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2016, 59 (02) : 145 - 152
  • [50] Statin Efficacy in Type 1 and Type 2 Diabetes Mellitus
    Ciriacks, Kevin
    Krishnaswami, Shanthi
    Patel, Shailendra
    Kidambi, Srividya
    DIABETES, 2013, 62 : A165 - A165
12345